The clinical relevance and newsworthiness of NIHR HTA-funded research: a cohort study

D Wright1, A Young, E Iserman

  • 1National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre (NETSCC), University of Southampton, Southampton, Hampshire, UK.

BMJ Open
|May 10, 2014
PubMed

Insights

The UK National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Programme successfully funds research with high clinical relevance. Their reports demonstrate significant value for healthcare investment and practice.

Area of Science:

  • Health Technology Assessment
  • Medical Research Funding
  • Clinical Relevance Evaluation

Background:

  • Assessing the impact of research funding is crucial for maximizing return on investment.
  • The UK National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Programme funds research to inform healthcare decisions.
  • Evaluating the clinical relevance and newsworthiness of funded research ensures its practical application.

Purpose of the Study:

  • To evaluate the clinical relevance and newsworthiness of reports funded by the NIHR HTA Programme.
  • To compare the quality of NIHR HTA publications with non-NIHR HTA publications.
  • To determine if NIHR HTA funding effectively supports research impactful for clinical practice.

Main Methods:

  • A retrospective cohort study analyzed 311 NIHR HTA Programme funded reports published between 2007 and 2012.
  • The McMaster Online Rating of Evidence (MORE) system, utilizing over 4000 physicians, assessed clinical relevance and newsworthiness.
  • Ratings were compared between NIHR HTA reports, non-NIHR HTA publications, and publications from the same studies appearing outside HTA.

Main Results:

  • 92.0% of NIHR HTA reports were assessed, with 67.1% meeting MORE inclusion criteria.
  • NIHR HTA reports showed statistically higher average clinical relevance (5.48) compared to non-NIHR HTA publications (5.32; p=0.01).
  • Average newsworthiness ratings were similar between NIHR HTA and non-NIHR HTA publications (4.75 vs. 4.70; p=0.402), though original research reports were more newsworthy than reviews (p=0.001).

Conclusions:

  • The NIHR HTA Programme effectively funds research that is clinically relevant.
  • The findings support the value of investing in research that directly impacts clinical practice.
  • The program demonstrates success in generating high-value research outputs for healthcare.
Abstract

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
627
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.7K
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
8.5K
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
247
Case Studies01:22

Case Studies

There are many research methods available to psychologists in their efforts to understand, describe, and explain behavior and the cognitive and biological processes that underlie it.
11.3K
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
1.6K